APA (7th ed.) Citation

Yan, Y., Zhang, C., Shen, L., Su, Y., Liu, X., Wang, L., & Gu, Z. (2018). Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer. Frontiers in Pharmacology, 9, . https://doi.org/10.3389/fphar.2018.00575

Chicago Style (17th ed.) Citation

Yan, Yi-Dan, Chi Zhang, Long Shen, Ying-Jie Su, Xiao-Yan Liu, Li-Wei Wang, and Zhi-Chun Gu. "Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer." Frontiers in Pharmacology 9 (2018). https://doi.org/10.3389/fphar.2018.00575.

MLA (9th ed.) Citation

Yan, Yi-Dan, et al. "Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Patients With Cancer." Frontiers in Pharmacology, vol. 9, 2018, https://doi.org/10.3389/fphar.2018.00575.